Skip to main content
Log in

An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney

Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The present study has identified a receptor for 5-hydroxytryptamine (5-HT) which functions to inhibit the stimulus-induced release of [3H] noradrenaline following sympathetic periarterial nerve stimulation to the isolated perfused rat kidney. In addition to 5-HT (IC30=4.5×10−8 mol/l), both 5-carboxamidotryptamine (IC30=8×10−9 mol/l) and 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl) indole (RU-24969, IC30=2.5×10−7 mol/l) acted as agonists whereas 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) was inactive. The inhibitory effect of 5-HT on the electrically-evoked release of tritium was antagonized in a concentration-dependent manner by methiothepin (IC50=4×10−9 mol/l), metergoline (IC50=4×10−8 mol/l) and methysergide (IC50=1.3×10−7 mol/l) but not by cyproheptadine, ketanserin, mesulergine, (−)-propranolol, (±)-pindolol, (±)-cyanopindolol, metoclopramide or phentolamine. It is concluded that the receptor to 5-HT conforms to general criteria defining 5-HT1-like receptors but at the present time the receptor site cannot be fitted to the designated 5-HT1A, 5-HT1B or 5-HT1C subtypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adler-Graschinsky E (1983) Dual presynaptic effects of 5-hydroxytryptamine on peripheral noradrenergic synapses. J Auton Pharmacol 3:303–315

    Google Scholar 

  • Asarch KB, Ransom RW, Shih JC (1985) 5-HT-1a and 5-HT-1b selectivity of the two phenylpiperazine derivatives: Evidence for 5-HT-1b heterogeneity. Life Sci 36:1265–1273

    Google Scholar 

  • Baumann PA, Waldmeier PC (1982) Further evidence for negative feedback control of serotonin release in the central nervous system. Naunyn-Schmiedeberg's Arch Pharmacol 317:36–43

    Google Scholar 

  • Charlton KG, Johnson TD, Clarke DE (1984) Vasoconstrictor and norepinephrine potentiating action of 5-hydroxykynuramine in the isolated perfused rat kidney: Involvement of serotonin receptors and alpha1-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 328:154–159

    Google Scholar 

  • Cohen ML (1984) Vascular serotonin receptors and blood pressure regulation. Drug Develop Res 4:301–313

    Google Scholar 

  • Connor HE, Feniuk W, Humphrey PPA, Perren MJ (1985) 5-Carboxamido-tryptamine is a selective agonist at 5-HT receptors mediating vasodilation and tachycardia in the anaesthetised cat. Br J Pharmacol 85:222P

  • Cortés E, Palacios JM, Pazos A (1984) Visualization of multiple serotonin receptors in the rat brain by autoradiography. Br J Pharmacol 82:202P

    Google Scholar 

  • Doxey JC, Roach AG, Smith CFC (1983) Studies on RX781094: A selective, potent and specific antagonist of α2-adrenoceptors. Br J Pharmacol 78:489–505

    Google Scholar 

  • Ekas RD, Steenberg ML, Woods MS, Lokhandwala MF (1983) Presynaptic α- and β-adrenoceptor stimulation and norepinephrine release in the spontaneously hypertensive rat. Hypertension 5:198–204

    Google Scholar 

  • Engel G, Göthert M, Müller-Schweinitzer E, Schlicker E, Sistonen L, Stadler PA (1983) Evidence for common pharmacological properties of [3H]-5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn-Schmiedeberg's Arch Pharmacol 324:116–124

    Google Scholar 

  • Feniuk W (1984) An analysis of 5-hydroxytryptamine receptors mediating contraction of isolated smooth muscle. Neuropharmacology 23:1467–1472

    Google Scholar 

  • Feniuk W, Humphrey PPA, Watts AD (1979) Presynaptic inhibitory action of 5-hydroxytryptamine in dog isolated saphenous vein. Br J Pharmacol 67:247–254

    Google Scholar 

  • Feniuk W, Humphrey PPA, Watts AD (1981a) Further characterization of pre- and post-junctional receptors for 5-hydroxytryptamine in isolated vasculature. Br J Pharmacol 73:191P-192P

    Google Scholar 

  • Feniuk W, Humphrey PPA, Watts AD (1981b) Modification of the vasomotor actions of methysergide in the femoral bed of the anesthetized dog by changes in the sympathetic nerve activity. J Auton Pharmacol 1:127–132

    Google Scholar 

  • Fozard JR (1983) Functional correlates of 5-HT1 recognition sites. Trends Pharmacol Sci 4:288–289

    Google Scholar 

  • Fozard JR (1984) Neuronal 5-HT receptors in the periphery. Neuropharmacology 23:1473–1486

    Google Scholar 

  • Gaddum JH, Picarelli ZP (1957) Two kinds of tryptamine receptor. Br J Pharmacol 12:323–328

    Google Scholar 

  • Göthert M, Schlicker E (1983) Autoreceptor-mediated inhibition of3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine. Life Sci 32:1183–1191

    Google Scholar 

  • Göthert M, Kollecker P (1985) Presynaptic 5-hydroxytryptamine1 (5-HT1) receptors on the sympathetic nerves of the human saphenous vein. Naunyn-Schmiedeberg's Arch Pharmacol 329:R83

    Google Scholar 

  • Gradin K, Petterson A, Hjorth S, Hedner T, Arvidsson LE, Persson B (1985) Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist. J Pharma Pharmacol 37: 263–265

    Google Scholar 

  • Hoyer D (1985) Characterization of multiple serotonin (5-HT) recognition sites in rat and pig brain membranes by radioligand binding. Naunyn-Schmiedeberg's Arch Pharmacol 329:R82

    Google Scholar 

  • Humphrey PPA (1984) Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology 23:1503–1510

    Google Scholar 

  • Humphrey PPA, Feniuk W, Watts AD (1983) Prejunctional effects of 5-hydroxytryptamine on noradrenergic nerves in the cardiovascular system. Fed Proc 42:218–222

    Google Scholar 

  • Kalkman HO, Boddeke HWGM, Doods HN, Timmermans PBMWM, van Zwieten PA (1983) Hypotensive activity of serotonin receptor agonists in rats is related to their affinity for 5-HT1 receptors. Eur J Pharmacol 91:155–156

    Google Scholar 

  • Kapur H, Mottram DR (1979) A pre-synaptic inhibitory effect of 5-hydroxytryptamine on the electrically induced twitch response of the rat vas deferens. Biochem Pharmacol 28:951–952

    Google Scholar 

  • Kawasaki H, Takasaki K (1984) Vasoconstrictor response induced by 5-hydroxytryptamine released from vascular adrenergic nerves by periarterial nerve stimulation. J Pharmacol Exp Ther 229:816–822

    Google Scholar 

  • Kimura T, Satoh S (1983) Presynaptic inhibition by serotonin of cardiac sympathetic transmission in dogs. Clin Exp Pharmacol Physiol 10:535–542

    Google Scholar 

  • Lawang A, Saxena PR (1985) Pharmacological comparison between 5-hydroxytryptamine (5-HT) and 5-carboxamide tryptamine (5-CT). Br J Pharmacol 85: 316P

  • Leysen J (1983) Serotonin receptor binding sites: Is there pharmacological and clinical significance? Med Biol 61:139–143

    Google Scholar 

  • Leysen J (1984) Problems inin vitro receptor binding studies and identification and role of serotonin receptor sites. Neuropharmacology 23:247–254

    Google Scholar 

  • Leysen JE (1985) Serotonin binding sites. In: Vanhoutte PM (ed) Serotonin and the cardiovascular system. Raven Press, New York, pp 43–62

    Google Scholar 

  • Leysen JE, Tollenaere JP (1982) Biochemical models for serotonin receptors. Annual Reports Med Chem 17:1–10

    Google Scholar 

  • Martin LL, Sanders-Bush E (1982a) Comparison of the pharmacological characteristics of 5-HT1 and 5-HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn-Schmiedeberg's Arch Pharmacol 321:165–170

    Google Scholar 

  • Martin LL, Sanders-Bush E (1982b) The serotonin autoreceptor: Antagonism by quipazine. Neuropharmacology 21:445–450

    Google Scholar 

  • Martinez AA, Lokhandwala MF (1980) Evidence for a presynaptic inhibitory action of 5-hydroxytryptamine on sympathetic neurotransmission to the myocardium. Eur J Pharmacol 63:303–311

    Google Scholar 

  • Middlemiss DN (1982) Multiple 5-hydroxytryptamine receptors in the central nervous system of the rat. In: Belleroche JD (ed) Presynaptic receptors: mechanism and function. Ellis Harwood Ltd, Chichester, pp 46–74

    Google Scholar 

  • Middlemiss DN (1984a) Stereospecific blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol. Eur J Pharmacol 101:289–293

    Google Scholar 

  • Middlemiss DN (1984b) 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site. Naunyn-Schmiedeberg's Arch Pharmacol 327:18–22

    Google Scholar 

  • Middlemiss DN (1984c) RU-24969 inhibits K+-evoked release of [3H]-5-HT from rat frontal cortex slices via stimulation of the 5-HT autoreceptor. 14th CINP Congr Florence 657P

  • Middlemiss DN, Fozard JR (1983) 8-Hydroxy-2-(DI-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol 90:151–153

    Google Scholar 

  • Middlemiss DN, Neill J, Tricklebank MD (1985) Subtypes of the 5-HT receptor involved in hypothermia and forepaw treading induced by 8-OH-DPAT. Proc Br Pharmacol Soc Cardiff

  • Nahorski SR, Willcocks AL (1983) Interactions of β-adrenoceptor antagonists with 5-hydroxytryptamine receptor subtypes in rat cerebral cortex. Br J Pharmacol 78:107P

    Google Scholar 

  • Pazos A, Hoyer D, Palacios JM (1984a) The binding of serotonergic ligands to the porcine choroid plexus: Characterization of a new type of serotonin recognition site. Eur J Pharmacol 106:539–546

    Google Scholar 

  • Pazos A, Hoyer D, Palacios JM (1984b) Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: Evidence for species differences in brain serotonin-2 receptors. Eur J Pharmacol 106:531–538

    Google Scholar 

  • Pedigo NW, Yamamura HI, Nelson DL (1981) Discrimination of multiple [3H]-5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem 36:220–226

    Google Scholar 

  • Peroutka SJ (1984) Vascular serotonin receptors: Correlation with 5-HT1 and 5-HT2 binding sites. Biochem Pharmacol 33:2349–2353

    Google Scholar 

  • Peroutka SJ, Snyder SH (1979) Multiple serotonin receptors: Differential binding of [3H]lysergic acid diethylamide and [3H] spiroperidol. Mol Pharmacol 16:687–699

    Google Scholar 

  • Peroutka SJ, Lebovitz RM, Snyder SH (1981) Two distinct central serotonin receptors with different physiological functions. Science 212:827–829

    Google Scholar 

  • Petrovic T, Bell C (1984) Small fluorescent cells in the rat kidney contain 5-hydroxytryptamine not a catecholamine. J Auton Nervous System 11:329–338

    Google Scholar 

  • Saxena PR, Verdouw PD (1985) 5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br J Pharmacol 84:533–544

    Google Scholar 

  • Saxena PR, Mylecharane EJ, Heiligers J (1985) Analysis of the heart rate effects of 5-hydroxytryptamine in the cat: Mediation of tachycardia by 5-HT-like receptors. Naunyn-Schmiedeberg's Arch Pharmacol 330:121–129

    Google Scholar 

  • Schlicker E, Hillenbrand K (1985) Antagonistic properties of β-adrenoceptor antagonists at presynaptic serotonin autoreceptors in the rat brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 329:R83

    Google Scholar 

  • Schurek HJ, Brecht JP, Lohfert H, Hierholzer K (1975) The basic requirements for the function of the isolated cell free perfused rat kidney. Pflügers Arch 359:349–365

    Google Scholar 

  • Sills MA, Wolfe BB, Frazer A (1984) Determination of selective and nonselective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231:480–487

    Google Scholar 

  • Stier CT, McKendall G, Itskovitz HD (1984) Serotonin formation in nonblood-perfused kidneys. J Pharmacol Exp Ther 228:53–56

    Google Scholar 

  • Timmermans PBMWM, Mathy M-J, Wilfert B, Kalkman HO, Smit G, Dijkstra D, Horn AS, van Zwieten PA (1984) 15-1 agonist selectivity of mono- and dihydroxy-2-N,N-di-n-propylaminotetralins. Eur J Pharmacol 97:55–65

    Google Scholar 

  • Tricklebank MD, Forler C, Fozard JR (1984) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(DL-n-propylamino) tetralin in the rat. Eur J Pharmacol 106:271–282

    Google Scholar 

  • Verbeuren TJ, Jordaens FH, Herman AG (1983) Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog. J Pharmacol Exp Ther 226:579–588

    Google Scholar 

  • Wallis D (1981) Neuronal 5-hydroxytryptamine receptors outside the central nervous system. Life Sci 29:2345–2355

    Google Scholar 

  • Watts AD, Feniuk W, Humphrey PPA (1981) A pre-junctional action of 5-hydroxytryptamine and methysergide on noradrenergic nerves in dog isolated saphenous vein. J Pharm Pharmacol 33:515–520

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Preliminary accounts of this work were presented to the British Pharmacological Society in London (December, 1984) and Southampton (July, 1985)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Charlton, K.G., Bond, R.A. & Clarke, D.E. An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 8–15 (1986). https://doi.org/10.1007/BF00633190

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00633190

Key words

Navigation